HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interstitial Lung Disease in Anti-Synthetase Syndrome.

Abstract
Anti-synthetase syndrome is an autoimmune disorder characterized by the presence of autoantibodies against aminoacyl transfer RNA (tRNA) synthetases, and myositis, interstitial lung disease (ILD), arthritis, fever and Raynaud's phenomenon (RP). We present a 54-year-old woman, who complained of fatigue, low-grade fever, myalgias, arthralgias, RP and dyspnoea on exertion. Chest CT scan revealed features of interstitial lung disease. Due to rapid deterioration of her lung function, she required oxygen support. The patient did not respond to empiric treatment with antibiotics. Autoantibody testing was remarkable for ANA positivity (1/160) and high-titre anti-Jo1 positivity. A diagnosis of anti-synthetase syndrome was made and the patient was placed on high-dose corticosteroids and rituximab with significant improvement. At 1-year follow up, she remains in good condition, without the need for oxygen supplementation.
AuthorsEvangelia Kourkouni, Georgios Mitsogiannis, Theodora Simopoulou, Christos Liaskos, Christina G Katsiari, Zoi Daniil, Konstantinos Gourgoulianis, Dimitrios P Bogdanos, Lazaros I Sakkas
JournalMediterranean journal of rheumatology (Mediterr J Rheumatol) Vol. 30 Issue 3 Pg. 186-189 (Sep 2019) ISSN: 2529-198X [Electronic] Greece
PMID32185363 (Publication Type: Case Reports)
Copyright© 2019 The Mediterranean Journal of Rheumatology (MJR).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: